128 related articles for article (PubMed ID: 9028537)
1. Collagen formation and degradation increase during growth hormone therapy in children.
Vihervuori E; Turpeinen M; Siimes MA; Koistinen H; Sorva R
Bone; 1997 Feb; 20(2):133-8. PubMed ID: 9028537
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
[TBL] [Abstract][Full Text] [Related]
3. Malnutrition, zinc supplementation and catch-up growth: changes in insulin-like growth factor I, its binding proteins, bone formation and collagen turnover.
Doherty CP; Crofton PM; Sarkar MA; Shakur MS; Wade JC; Kelnar CJ; Elmlinger MW; Ranke MB; Cutting WA
Clin Endocrinol (Oxf); 2002 Sep; 57(3):391-9. PubMed ID: 12201833
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH.
Kamp GA; Zwinderman AH; Van Doorn J; Hackeng W; Frölich M; Schönau E; Wit JM
Clin Endocrinol (Oxf); 2002 Sep; 57(3):315-25. PubMed ID: 12201823
[TBL] [Abstract][Full Text] [Related]
5. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
[TBL] [Abstract][Full Text] [Related]
6. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
Crofton PM; Ahmed SF; Wade JC; Stephen R; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
[TBL] [Abstract][Full Text] [Related]
7. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
Crofton PM; Stirling HF; Schönau E; Kelnar CJ
Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
[TBL] [Abstract][Full Text] [Related]
8. New markers of bone and collagen turnover in children and adults with growth hormone deficiency.
Sartorio A; Conti A; Monzani M
Postgrad Med J; 1993 Nov; 69(817):846-50. PubMed ID: 8290428
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor axis, bone and collagen turnover in children with atopic dermatitis treated with topical glucocorticosteroids.
Wolthers OD; Heuck C; Ternowitz T; Heickendorff L; Nielsen HK; Frystyk J
Dermatology; 1996; 192(4):337-42. PubMed ID: 8864369
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.
Guha N; Erotokritou-Mulligan I; Nevitt SP; Francis M; Bartlett C; Cowan DA; Bassett EE; Sönksen PH; Holt RI
Drug Test Anal; 2013; 5(11-12):843-9. PubMed ID: 24173773
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy.
Kubo T; Tanaka H; Inoue M; Kanzaki S; Seino Y
Bone; 1995 Oct; 17(4):397-401. PubMed ID: 8573414
[TBL] [Abstract][Full Text] [Related]
12. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
[TBL] [Abstract][Full Text] [Related]
13. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
[TBL] [Abstract][Full Text] [Related]
14. Collagen metabolites in the prediction of response to GH therapy in short children.
Tapanainen P; Knip M; Risteli L; Kemppainen L; Käär ML; Risteli J
Eur J Endocrinol; 1997 Dec; 137(6):621-5. PubMed ID: 9437226
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover.
Sartorio A; Conti A; Monzani M; Morabito F; Faglia G
J Endocrinol Invest; 1993 Dec; 16(11):893-8. PubMed ID: 8144866
[TBL] [Abstract][Full Text] [Related]
16. Effects of 12 months rhGH treatment on bone and collagen turnover in children with constitutional growth delay.
Sartorio A; Conti A; Ferrero S; Saraifoger S; Resnik M; Baroncelli GI
J Pediatr Endocrinol Metab; 1999; 12(6):833-8. PubMed ID: 10614540
[TBL] [Abstract][Full Text] [Related]
17. Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on-the-field.
Sartorio A; Marazzi N; Agosti F; Faglia G; Corradini C; De Palo E; Cella S; Rigamonti A; Muller EE
J Endocrinol Invest; 2004 May; 27(5):410-5. PubMed ID: 15279071
[TBL] [Abstract][Full Text] [Related]
18. The changes in serum type I and III procollagen, insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in children with chronic renal failure.
Cinaz P; Buyan N; Gökçora N; Elbe S; Hasanoğlu E
J Trop Pediatr; 1996 Oct; 42(5):271-5. PubMed ID: 8936957
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]